Chris Boerner, PhD - Bristol Myers Squibb
Chris Boerner, PhD
Executive Vice President, Chief Commercialization Officer
Christopher Boerner is chief commercialization officer of Bristol Myers Squibb, where he leads commercial strategy and execution across all geographies. He also currently serves as the executive sponsor of the Bristol Myers Squibb Network of Women (B-NOW) People and Business Resource Group. In his previous role, Chris was head of international markets at Bristol Myers Squibb, accountable for commercial activities in all ex-U.S. markets. He joined the company in February 2015.
“I look forward to continuing to help BMS deliver on our mission of bringing transformational medicines to patients,” Chris said. “By focusing on innovation and execution, we can strengthen our ability to bring innovative medicines to patients faster.”
Prior to joining Bristol Myers Squibb, Chris served as the executive vice president of commercial for Seattle Genetics, Inc., where he led all commercial activities for the company, as well as senior vice president of commercial and vice president of marketing.
Before joining Seattle Genetics, Chris worked for Dendreon Corporation, where he led the marketing team. From 2002 to 2010, he worked for Genentech, a member of the Roche Group, where he served in a variety of commercial roles, including director of marketing on Avastin®. Prior to Genentech, he worked for McKinsey & Company, serving global pharmaceutical and biotechnology clients.
Chris received his PhD and MA in business administration from the Haas School of Business at the University of California, Berkeley, and holds an AB in economics and history from Washington University in St. Louis.
Updated: November 2021